コンテンツへスキップ
Merck

1.50182

Hibar® RT HPLC Columns for customized packing

L × I.D. 250 mm × 4 mm, please select HPLC sorbent for Column filling

別名:

TM=["Hibar"] RT column for customized packing

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

UNSPSC Code:
41115709
NACRES:
SB.52
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


製品名

Hibar® 250-4, suitable for HPLC

parameter

400 bar pressure

Quality Segment

technique(s)

HPLC: suitable

column L × I.D.

25 cm × 4 mm

separation technique

supercritical fluid (SFC)

storage temp.

no temp limit

General description

HPLC column, customized packing, please specify packing material

Application

  • High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis: This study highlights the utilization of high-performance liquid chromatography (HPLC) for analyzing complex mixtures in pharmaceuticals and biological samples, demonstrating the sophisticated capabilities of devices like Hibar 250-4 in handling and analyzing precision samples in high-stakes environments such as pharmaceutical quality control and medical diagnostics (Shaikh JSA, Raut S, Abdul A, Pathan MAAK, 2020).
  • Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: The research involves advanced chromatographic techniques which could be relevant for applications using Hibar 250-4 pumps in rigorous testing environments to identify and quantify degradation products, ensuring drug safety and efficacy (Udutha S, Shankar G, Borkar RM, et al., 2018).
  • Accumulation and trends in distribution of three triterpenoids in various parts of Achyranthes coynei determined using RP-UFLC analysis: This publication shows the application of ultra-fast liquid chromatography, a field where Hibar 250-4′s precision dosing could be pivotal, in the pharmacognostic study of plant materials, aiding in the rapid and effective separation of complex natural products (Upadhya V, Ankad GM, Pai SR, et al., 2014).
  • Development and validation of a HPLC-PDA bioanalytical method for the simultaneous estimation of Aliskiren and Amlodipine in human plasma: This study presents a validated method for the simultaneous estimation of two pharmaceutical agents in plasma, using HPLC systems like Hibar 250-4 to achieve high precision and accuracy required for therapeutic drug monitoring and pharmacokinetic studies (Mannemala SS, Nagarajan JS, 2015).

Legal Information

Hibar is a registered trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

Explore all of our products under Hibar® 250-4




試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする